(Q46086073)

19 December 2017

title

Suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in pituitary adenoma cells (English)

1 reference

19 December 2017

1 reference

S R Sangeetha

1

1 reference

19 December 2017

Nagendra Singh

series ordinal

2

1 reference

19 December 2017

John R Vender

series ordinal

3

1 reference

19 December 2017

Krishnan M Dhandapani

series ordinal

4

1 reference

19 December 2017

publication date

17 March 2009

1 reference

19 December 2017

published in

Endocrine

1 reference

19 December 2017

volume

35

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

389-396

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s12020-009-9159-1

exact match

0 references

cites work

Enhanced protein kinase B/Akt signalling in pituitary tumours

1 reference

12 December 2020

Hyperprolactinemia: etiology, diagnosis, and management

1 reference

12 December 2020

The nucleosome: a powerful regulator of transcription

1 reference

12 December 2020

Ras mutations in human pituitary tumors

1 reference

12 December 2020

Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid

1 reference

12 December 2020

Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.

1 reference

12 December 2020

Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model

1 reference

12 December 2020

SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway

1 reference

12 December 2020

Transcriptional analysis of human survivin gene expression

1 reference

12 December 2020

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells

1 reference

12 December 2020

Diagnosis and management of nonfunctioning pituitary tumors

1 reference

12 December 2020

Pituitary adenomas: results of 684 surgically treated patients and review of the literature

1 reference

12 December 2020

Chemically synthesized human survivin does not inhibit caspase-3.

1 reference

12 December 2020

Clonal origin of pituitary adenomas

1 reference

12 December 2020

Functional significance of histone deacetylase diversity

1 reference

12 December 2020

Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis

1 reference

12 December 2020

Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms

1 reference

12 December 2020

Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells

1 reference

12 December 2020

Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines.

1 reference

12 December 2020

Acute Stimulated Hormone Release from Cultured GH3Pituitary Cells*

1 reference

12 December 2020

Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.

1 reference

12 December 2020

Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.

1 reference

12 December 2020

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

1 reference

12 December 2020

Enrichment of regulatory CD4(+)CD25(+) T cells by inhibition of phospholipase D signaling

1 reference

12 December 2020

Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity

1 reference

12 December 2020

Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.

1 reference

12 December 2020

Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.

1 reference

12 December 2020

Radiosurgery for pituitary adenomas

1 reference

12 December 2020

Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects

1 reference

12 December 2020

Anticancer activities of histone deacetylase inhibitors

1 reference

12 December 2020

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

1 reference

12 December 2020

Histone acetyltransferases

1 reference

12 December 2020

CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation

1 reference

12 December 2020

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

1 reference

12 December 2020

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Survivin expression in pituitary adenomas

1 reference

12 December 2020

Novel histone deacetylase inhibitors in the treatment of thyroid cancer

1 reference

12 December 2020

Pituitary tumors: pathophysiology, clinical manifestations and management

1 reference

12 December 2020

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

12 December 2020

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer

1 reference

12 December 2020

Genetic basis of pituitary adenoma invasiveness: a review

1 reference

12 December 2020

Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin

1 reference

12 December 2020

Tolerance of cranial nerves of the cavernous sinus to radiosurgery

1 reference

12 December 2020

Histone deacetylase inhibitors: molecular mechanisms of action

1 reference

12 December 2020

Surgery and radiotherapy: complementary tools in the management of benign intracranial tumors

1 reference

12 December 2020

The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery

1 reference

12 December 2020

Histone acetylation and transcriptional regulatory mechanisms

1 reference

12 December 2020

Histone acetyltransferases: function, structure, and catalysis

1 reference

12 December 2020

Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications

1 reference

12 December 2020

10.1007/S12020-009-9159-1

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017